Back to search

France· FR:61035382

SPASMAG INJECTABLE, solution injectable (IV) en ampoule

A medicinal product containing magnésium (sulfate de) heptahydraté, registered in France by GRIMBERG, on the national reimbursement list.

Reimbursed in France (Assurance maladie)

Checked against Base de données publique des médicaments — BDPM (France) on

Informational only — not a medical device.

SOURCE REGISTER · FRBase de données publique des médicament…normalisedSPASMAG INJECTABLE, solution injectab…ATC—REGISTER NO.FR:61035382PACKS LISTED1CHECKEDSeptember 12, 2026

The record

At a glance

Base de données publique des médicaments — BDPM (France)
Active substance
MAGNÉSIUM (SULFATE DE) HEPTAHYDRATÉ
Manufacturer
GRIMBERG
Country
France (FR)
ATC code
—
Reimbursed
Yes
Source register
Base de données publique des médicaments — BDPM (France)
Last checked
September 12, 2026

Packs & prices · 1

1 priced
  • cip13
    3400930083062
    10 ampoule(s) bouteille en verre de 10 ml
    EUR 9.59

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Magnésium (sulfate de) heptahydraté in 11 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All magnésium (sulfate de) heptahydraté products

Authorised across Europe · EMA

The same active substance is authorised in 5 EEA countries. Names it is sold under:

  • Denmark · Magnesiumsulfat Sad
  • United Kingdom (Northern Ireland) · Magnesium Sulphate Phoenix Labs
  • Greece · Magnesium Sulfate Ariti
  • Ireland · Magnesium Sulfate Foran Healthcare
  • Netherlands · Magnesiiumsulfaat Teva, Magnesiumsulfaat Teva

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/7572e0f5-a192-4a0b-953d-2827328ef141
GET /v1/drugs/7572e0f5-a192-4a0b-953d-2827328ef141?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "cis": "61035382",
  "date_amm": "1982-10-21",
  "type_amm": "Procédure nationale",
  "numero_ue": null,
  "substance": "MAGNÉSIUM (SULFATE DE) HEPTAHYDRATÉ",
  "statut_amm": "Autorisation active",
  "statut_bdm": null,
  "forme_pharmaceutique": "solution injectable",
  "voies_administration": "intraveineuse",
  "etat_commercialisation": "Commercialisée",
  "surveillance_renforcee": "Non"
}

See everything about magnésium (sulfate de) heptahydraté.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.